View up-to-date information on BridgeBio Pharma Inc’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
---|---|---|---|---|
21 Jul 2022 | BridgeBio Pharma Enters into Collaboration with Baylor College of Medicine | Partnership | - |
BridgeBio Pharma Inc
Baylor College of Medicine
|
13 May 2022 | BridgeBio Pharma to Sell Rare Pediatric Disease PRV for USD110 Million | Asset Transaction | - |
BridgeBio Pharma Inc |
12 May 2022 | Bristol Myers Squibb Enters into Licensing Agreement with BridgeBio Pharma | Licensing Agreement |
Bristol-Myers Squibb Co
|
BridgeBio Pharma Inc |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer